The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
Top Cited Papers
Open Access
- 14 March 2005
- journal article
- policy forum
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 2 (4), e100
- https://doi.org/10.1371/journal.pmed.0020100
Abstract
The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action.Keywords
This publication has 18 references indexed in Scilit:
- Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross‐sectional survey on the prevalence of fake antimalarialsTropical Medicine & International Health, 2004
- The global distribution and population at risk of malaria: past, present, and futureThe Lancet Infectious Diseases, 2004
- Drug regulators study global treaty to tackle counterfeit drugsBMJ, 2004
- India agrees to help Nigeria tackle the import of fake drugsBMJ, 2003
- Who will take responsibility for corporate killing?The Lancet, 2003
- Identification of the ?wrong? active pharmaceutical ingredient in a counterfeit Halfan? drug product using accurate mass electrospray ionisation mass spectrometry, accurate mass tandem mass spectrometry and liquid chromatography/mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Murder by fake drugsBMJ, 2002
- Epidemic of Pediatric Deaths From Acute Renal Failure Caused by Diethylene Glycol PoisoningJAMA, 1998
- Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemicBMJ, 1995
- Death over the counter.BMJ, 1983